Ki67 and salivary cancer

Area of Science:

• Oncology
• Pathology

Background:

• Salivary malignancies are rare cancers with variable prognoses.
• Understanding prognostic markers is crucial for patient management.

Purpose of the Study:

• To investigate the prognostic significance of Ki67 expression in salivary malignancies.
• To correlate Ki67 expression with other markers like p53, TUNEL, and heparanase.

Main Methods:

• Analysis of Ki67 expression in tumor samples from 75 patients.
• Correlation of Ki67 staining levels with patient survival data (up to 20 years).
• Assessment of co-expression with p53, TUNEL, and heparanase.

Main Results:

• Significant correlation found between elevated Ki67 expression and poorer survival.
• Patients with high Ki67 (>5%) had a median survival of 39 months versus 163 months for low Ki67 (<=5%).
• Five-year survival probability was 33% for high Ki67 vs. 93% for low Ki67.

Conclusions:

• Ki67 expression is a significant prognostic indicator in salivary malignancies.
• Altered expression of Ki67, p53, and other markers suggests a role in cancer pathogenesis.
• Ki67 may serve as a valuable biomarker for predicting outcomes in salivary cancer.